Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jodas Expoim is a global pharmaceutical company headquartered in India, specializing in the development and manufacturing of a wide range of generic formulations. The company maintains a significant presence in international markets, particularly in the CIS region, and operates state-of-the-art manufacturing facilities that comply with global regulatory standards. Their product portfolio spans multiple therapeutic areas, including anti-infectives, oncology, contrast media, and critical care. Jopamol-F is one of their commercialized products, typically formulated as a combination analgesic and antipyretic for the management of pain and fever.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jopamol-F Tablets.